Tetagam P

Tetagam P is a human tetanus immunoglobulin used to prevent tetanus infection after potential exposure. It provides passive immunity by delivering antibodies against tetanus toxin. This product is administered via intramuscular injection and is derived from plasma. Ideal for post-exposure prophylaxis in non-immunized individuals.

Human Tetanus Immunoglobulin, or Tetagam P, is used to prevent tetanus infection following injuries with potential contamination, such as cuts or puncture wounds. It is also administered to individuals with uncertain or incomplete tetanus immunization histories. The product works by providing immediate antibodies to neutralize tetanus toxin. It does not replace the need for tetanus vaccination but offers temporary protection.

Tetagam P provides passive immunity by supplying pre-formed antibodies against tetanus toxin, offering immediate protection. Users may experience mild effects such as soreness or redness at the injection site. Some individuals might notice general fatigue or headache shortly after administration. These effects are typically temporary and resolve within a few days.

Tetagam P should be stored refrigerated and protected from freezing. It must be administered by a healthcare professional in a clinical setting. Individuals with known allergies to human immunoglobulin products should avoid this medication. Pregnant or breastfeeding individuals should consult a healthcare provider before use. Always disclose your full medical history to your healthcare provider.

Tetagam P may interact with live vaccines, potentially reducing their effectiveness. It is not known to interact with most medications, but caution is advised when used alongside immunosuppressants. Alcohol consumption does not directly interact with the product but may impair wound healing. Always inform your healthcare provider about all medications and supplements you are taking.